Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

LEGN

Legend Biotech Corp ADR

Dec 01 • 04:00PM ET

59.99

Dollar change -0.83
Percentage change -1.36	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.58	Insider Own	0.86%	Shs Outstand	181.79M	Perf Week	-0.83%
Market Cap	10.91B	Forward P/E	-	EPS next Y	-1.35	Insider Trans	0.00%	Shs Float	180.23M	Perf Month	-10.21%
Income	-398.81M	PEG	-	EPS next Q	-0.30	Inst Own	46.91%	Short Float / Ratio	4.93% / 13.37	Perf Quarter	-16.20%
Sales	128.37M	P/S	84.95	EPS this Y	3.54%	Inst Trans	18.76%	Short Interest	8.88M	Perf Half Y	-5.35%
Book/sh	7.37	P/B	8.14	EPS next Y	-0.06%	ROA	-	Target Price	87.69	Perf Year	16.46%
Cash/sh	7.83	P/C	7.66	EPS next 5Y	-	ROE	-	52W Range	42.90 - 77.32	Perf YTD	20.17%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-24.06%	52W High	-22.41%	Beta	-0.01
Dividend %	-	Quick Ratio	8.51	Sales past 5Y	43.51%	Gross Margin	-	52W Low	39.82%	ATR	2.80
Employees	1387	Current Ratio	8.61	Sales Q/Q	702.05%	Oper. Margin	-348.16%	RSI (14)	40.91	Volatility	4.50% 4.42%
Optionable	Yes	Debt/Eq	0.24	EPS Q/Q	72.57%	Profit Margin	-310.68%	Rel Volume	1.40	Prev Close	60.82
Shortable	Yes	LT Debt/Eq	0.24	Earnings	Nov 20 BMO	Payout	-	Avg Volume	664.04K	Price	59.99
Recom	1.29	SMA20	-4.77%	SMA50	-7.30%	SMA200	-5.49%	Volume	931,024	Change	-1.36%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-06-23	Initiated	Goldman	Buy	$90.09
May-25-23	Initiated	William Blair	Mkt Perform	$64
May-22-23	Initiated	Daiwa Securities	Buy
Mar-29-23	Initiated	H.C. Wainwright	Buy	$66
Mar-24-23	Initiated	RBC Capital Mkts	Outperform	$73
Dec-06-22	Initiated	UBS	Buy	$66
Nov-02-22	Initiated	Evercore ISI	Outperform
Nov-01-22	Initiated	Cowen	Outperform
Oct-31-22	Initiated	Guggenheim	Neutral
Jun-17-22	Initiated	BMO Capital Markets	Outperform	$77
Mar-15-22	Initiated	Barclays	Overweight	$53
Jan-31-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$51
Jan-06-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-21-21	Initiated	Piper Sandler	Overweight	$66
May-18-21	Initiated	BTIG Research	Buy	$55
Jul-01-20	Initiated	JP Morgan	Overweight	$50
Jul-01-20	Initiated	Jefferies	Buy	$47
Jun-30-20	Initiated	Morgan Stanley	Overweight	$55

Show Previous Ratings

Nov-28-23 02:51PM	FDA Looking Into All Approved CAR T Therapies on Risk of Cancer in White Blood Cells (The Wall Street Journal)
Nov-24-23 04:02PM	Legend Biotech Corporation (NASDAQ:LEGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-20-23 11:09PM	Q3 2023 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents) -6.29%
06:00AM	Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights (Business Wire)
Nov-16-23 05:50AM	Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On (Motley Fool)
10:47AM	Loading…
Nov-14-23 10:47AM	Should You Buy Legend Biotech (LEGN) Ahead of Earnings? (Zacks)
Nov-13-23 08:30AM	Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3 (Business Wire)
07:00AM	Novartis licenses Legend cell therapy for lung cancer (BioPharma Dive)
Nov-07-23 08:30AM	Legend Biotech to Host Investor Conference Call on Third-Quarter Results (Business Wire)
Nov-02-23 09:17AM	Legend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual Meeting (Business Wire)
Oct-30-23 10:39AM	Should You Expect Strong Financial Growth from Legend Biotech Corporation (LEGN)? (Insider Monkey)
Oct-20-23 05:10AM	Should You Hold Legend Biotech Corporation (LEGN)? (Insider Monkey)
Oct-03-23 05:52AM	Legend Biotech Corporation (LEGN)'s Stock Witnessed a 43% Increase in Q2 (Insider Monkey)
Sep-21-23 08:00AM	Blockbuster Cancer Treatment Stymied by Supply Chainfor Now (The Wall Street Journal)
Aug-16-23 02:40AM	Q2 2023 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
06:00AM	Loading…
Aug-15-23 06:00AM	Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights (Business Wire)
Aug-14-23 08:36AM	Why Earnings Season Could Be Great for Legend Biotech (LEGN) (Zacks)
07:15AM	3 Biotech Stocks Poised to Beat Q2 Earnings Estimates (Zacks)
Aug-10-23 08:14AM	Top 5 Stocks Set to Beat on Earnings Next Week (Zacks)
Aug-07-23 06:57PM	3 Biotech Stocks That Analysts Are Drooling Over (InvestorPlace)
Aug-03-23 08:30AM	Legend Biotech to Host Investor Conference Call on Second-Quarter Results (Business Wire)
Aug-02-23 09:56AM	AMD upgraded, Electronic Arts downgraded: Wall Street's top analyst calls (The Fly)
Jul-25-23 02:45AM	What Makes Legend Biotech Corporation (LEGN) a Unique and Exciting Investment Opportunity? (Insider Monkey)
Jun-29-23 02:00AM	This Top-Performing Small-Cap Manager Is Betting Big on China (Barrons.com)
Jun-07-23 08:35AM	Legend (LEGN) Up 4% on sNDA Submission for Carvykti Expanded Use (Zacks)
Jun-06-23 04:30PM	Legend Biotech Announces Submission of Supplemental Application to the U.S. FDA for Expanded Use of CARVYKTI® (ciltacabtagene autoleucel) (Business Wire)
Jun-05-23 11:04AM	Ciltacabtagene Autoleucel (cilta-cel) Reduced Risk of Disease Progression or Death by 74% vs Standard Regimens for Adult Patients with Relapsed and Refractory Multiple Myeloma in CARTITUDE-4 Study (Business Wire)
Jun-02-23 04:01PM	Legend Biotech Announces Participation in Upcoming Investor Conferences (Business Wire)
May-25-23 08:30AM	Legend Biotech Announces Submission to the European Medicines Agency for Expanded Use of CARVYKTI® (ciltacabtagene autoleucel) (Business Wire)
May-23-23 03:14PM	Legend Biotech's Story Is Still Playing Out (TheStreet.com)
08:30AM	Loading…
May-18-23 08:30AM	Legend Biotech Reports First Quarter 2023 Results and Recent Highlights (Business Wire)
May-16-23 08:35AM	Legend Biotech to Demonstrate Progress in Advancing Potential Treatment Options for Patients with Multiple Myeloma at ASCO and EHA Annual Meetings (Business Wire)
May-11-23 04:01PM	Legend Biotech Announces Participation in Upcoming Investor Conference (Business Wire)
May-08-23 08:30AM	Legend Biotech Corporation Announces Pricing of Registered Direct Offering of $350 Million of American Depositary Shares (Business Wire)
May-03-23 10:25PM	Voyager Therapeutics (VYGR) Surges 11.1%: Is This an Indication of Further Gains? (Zacks)
May-01-23 09:25AM	After Jumping 49% in 1 Month, Is It Too Late to Buy Legend Biotech? (Motley Fool)
Apr-21-23 04:03PM	Legend Bio Hits Profit-Taking Zone After Confirming Leaked Test Results (Investor's Business Daily) +9.33%
Apr-20-23 11:04AM	Legend (LEGN) Stock Up 20% on Data Leak From Blood Cancer Study (Zacks)
01:52AM	Legend Biotech Corporation Sponsored ADR (LEGN) Soars 19.6%: Is Further Upside Left in the Stock? (Zacks)
Apr-19-23 07:22PM	7 Biotech Stocks That Could Cure Your Portfolio Woes (InvestorPlace) +19.64%
04:06PM	Legend Breaks Out After Leaked Documents Show Promise In $9.6 Billion Market (Investor's Business Daily)
01:04PM	Legend Biotech Soars After Cancer Drug Trial Results Revealed Early (Bloomberg)
12:40PM	Why Shares of Legend Biotech Jumped Wednesday (Motley Fool)
10:22AM	Legend Biotech Breaks Out After Leaked Documents Show Big CAR-T Benefit (Investor's Business Daily)
Apr-11-23 08:30AM	Legend Biotech Announces Appointment of Chief Medical Officer (Business Wire)
Apr-03-23 04:01PM	Legend Biotech Establishes Strategic Advisory Board (Business Wire)
Apr-02-23 09:49AM	Analysts Are Upgrading Legend Biotech Corporation (NASDAQ:LEGN) After Its Latest Results (Simply Wall St.)
Apr-01-23 09:45AM	Legend Biotech's (NASDAQ:LEGN) growing losses don't faze investors as the stock rises 4.7% this past week (Simply Wall St.)
09:00AM	Legend Biotech Full Year 2022 Earnings: Revenues Miss Expectations (Simply Wall St.)
Mar-30-23 04:01PM	Legend Biotech Reports Full-Year 2022 Results and Recent Highlights (Business Wire)
Mar-29-23 08:54PM	7 Biotech Stocks to Buy for Breakthrough Treatments and Cures (InvestorPlace)
04:40PM	12 Most Promising Healthcare Stocks According to Analysts (Insider Monkey)
Mar-24-23 02:47AM	Should You Retain Your Holdings in Legend Biotech Corporation (LEGN)? (Insider Monkey) +5.11%
Feb-25-23 11:38AM	10 Most Promising Biotech Stocks According to Analysts (Insider Monkey)
Feb-24-23 08:30AM	Legend Biotech Announces Participation in Upcoming Investor Conferences (Business Wire)
Feb-21-23 08:30AM	Legend Biotech Regains Compliance with NASDAQ Listing Rule 5250(c)(2) (Business Wire)
Jan-27-23 09:54AM	UPDATE 1-J&J says blood cancer drug improves progression-free survival in patients (Reuters)
08:32AM	Legend Biotech Announces Phase 3 CARTITUDE-4 Study of CARVYKTI® (ciltacabtagene autoleucel) Has Met Its Primary Endpoint in the Treatment of Patients with Relapsed and Refractory Multiple Myeloma (Business Wire)
Jan-03-23 04:01PM	Legend Biotech to Participate in the 41st Annual JP Morgan Healthcare Conference (Business Wire)
Jan-02-23 04:45AM	Legend Biotech Announces Acceptance of Its New Drug Application for Ciltacabtagene Autoleucel (Cilta-Cel) in China (Business Wire)
Dec-26-22 08:37PM	Is Legend Biotech Corporation (LEGN) A Good Investment? (Insider Monkey)
Dec-14-22 05:37AM	Is Legend Biotech Corporation (NASDAQ:LEGN) Trading At A 44% Discount? (Simply Wall St.)
Nov-21-22 08:30AM	Legend Biotech Announces FDA Clearance of IND Application for LB2102 in Extensive Stage Small Cell Lung Cancer (Business Wire)
Nov-04-22 05:00PM	Legend Biotech Announces Participation in Upcoming Investor Conferences (Business Wire)
Nov-03-22 04:01PM	Legend Biotech Shares Updated Data from Comprehensive Cilta-Cel Clinical Development Program at ASH 2022 (Business Wire)
Oct-19-22 11:51AM	Legend's (LEGN) Q3 Carvykti Preliminary Sales Top Expectations (Zacks)
Oct-18-22 05:14PM	Why Legend Biotech's Shares Jumped 14.2% On Tuesday (Motley Fool) +14.20%
Oct-10-22 01:38PM	Shareholders in Legend Biotech (NASDAQ:LEGN) are in the red if they invested a year ago (Simply Wall St.)
Sep-27-22 09:09AM	CARVYKTI (ciltacabtagene autoleucel) Receives Approval from Japans Ministry of Health, Labour and Welfare (MHLW) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (Business Wire)
Sep-15-22 08:30AM	Legend Biotech to Host 2022 R&D Day on Monday, October 3, 2022 (Business Wire)
Sep-01-22 02:07PM	Legend Biotech Stock Joins Elite Club Of Stocks With RS Ratings Over 90 (Investor's Business Daily)
Aug-19-22 04:01PM	Legend Biotech Announces Participation in Upcoming Investor Conferences (Business Wire)
Aug-16-22 10:13AM	Should You Buy Legend Biotech (LEGN) Ahead of Earnings? (Zacks)
Aug-05-22 08:30AM	Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2022 (Business Wire)
Aug-04-22 04:01PM	Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board (Business Wire)
Jul-31-22 06:23AM	Analysts Say These 3 Stocks Are Their Top Picks for the Rest of 2022 (TipRanks)
Jul-28-22 08:30AM	Legend Biotech Corporation Sponsored ADR (LEGN) Soars 10.9%: Is Further Upside Left in the Stock? (Zacks)
Jul-27-22 05:58PM	Why Legend Biotech's Shares Jumped 11.8% on Wednesday (Motley Fool) +10.85%
Jul-26-22 08:00PM	Legend Biotech Corporation Announces Pricing of Public Offering (Business Wire) -13.88%
Jul-25-22 04:01PM	Legend Biotech Corporation Announces Proposed Public Offering (Business Wire)
Jul-20-22 10:11AM	Health Check: How Prudently Does Legend Biotech (NASDAQ:LEGN) Use Debt? (Simply Wall St.) -7.27%
Jun-17-22 02:24PM	Legend Biotech Shares Move Higher After Bullish BMO Pitch (Benzinga) +7.61%
Jun-10-22 05:00PM	ASCO 2022: Surprising News in Cancer Research (Motley Fool)
Jun-05-22 09:10AM	Rainbows and Unicorns: Legend Biotech Corporation (NASDAQ:LEGN) Analysts Just Became A Lot More Optimistic (Simply Wall St.)
Jun-04-22 09:00AM	Longer-Term Data from CARTITUDE Program Continue to Show Deep and Durable Responses with Ciltacabtagene Autoleucel Across Lines of Therapy in Patients with Multiple Myeloma (Business Wire)
Jun-03-22 08:30AM	Legend Biotech Announces U.S. FDA Clearance of IND Application for Solid Tumor CAR-T, LB1908 for Relapsed or Refractory Gastric, Esophageal and Pancreatic Cancers (Business Wire) +6.36%
Jun-01-22 08:30AM	Legend Biotech Reports First Quarter 2022 Financial Results and Recent Highlights (Business Wire)
May-31-22 04:01PM	Legend Biotech to Host Investors at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (Business Wire)
May-26-22 03:10AM	CARVYKTI® (ciltacabtagene autoleucel) Granted Conditional Approval by the European Commission for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma (Business Wire)
May-18-22 08:30AM	Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma With Updated Data From BCMA CAR-T Studies at 2022 ASCO and EHA (Business Wire)
May-09-22 06:30AM	Legend Biotech Appoints Lori Macomber as Chief Financial Officer (Business Wire) -7.14%
May-06-22 04:01PM	Legend Biotech Announces Participation in Upcoming Investor Conferences (Business Wire) -6.25%
May-03-22 01:31PM	Investors ignore increasing losses at Legend Biotech (NASDAQ:LEGN) as stock jumps 7.3% this past week (Simply Wall St.)
Apr-06-22 07:01AM	2 Biotechs With Recent FDA Approvals to Hold for the Next Decade (Motley Fool)
Apr-01-22 04:01PM	Legend Biotech Announces Appointment of Global Head of Research and Early Development (Business Wire) +7.59%
Mar-25-22 08:01AM	CARVYKTI® (ciltacabtagene autoleucel) Receives Positive CHMP Opinion for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma (Business Wire) -5.07%
07:52AM	UPDATE 2-European drug regulator clears J&J, Legend's CAR-T therapy (Reuters)
Mar-23-22 08:30AM	Flanders Investment and Trade Names Legend Biotech Newcomer of the Year (Business Wire)
Mar-18-22 04:01PM	Legend Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights (Business Wire)
Mar-09-22 04:52AM	Legend Biotech Corporation's (NASDAQ:LEGN) Shift From Loss To Profit (Simply Wall St.) +5.09%

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LEGN

Legend Biotech Corp ADR

Upgrade your FINVIZ experience